A cost-utility analysis of ablative therapy for Barrett's esophagus.
暂无分享,去创建一个
[1] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[2] A. Sonnenberg,et al. Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. , 2008, Gastrointestinal endoscopy.
[3] C. Sempoux,et al. Stepwise radical endoscopic resection for Barrett’s esophagus with early neoplasia: report on a Brussels’ cohort , 2008, Endoscopy.
[4] Kenneth J. Chang,et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. , 2008, Gastrointestinal endoscopy.
[5] P. Fockens,et al. Eradication of Barrett Esophagus with Early Neoplasia by Radiofrequency Ablation, with or without Endoscopic Resection , 2008, Journal of Gastrointestinal Surgery.
[6] Kenneth J. Chang,et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.
[7] D. Fleischer,et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). , 2008, Endoscopy.
[8] P. Fockens,et al. A Promising New Combined Treatment Modality for Barrett's Esophagus Containing Early Neoplasia: Endoscopic Resection Followed By Step-Wise Circumferential and Focal Radiofrequency Energy Ablation , 2008 .
[9] Kenneth J. Chang,et al. 213 A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial , 2008 .
[10] P. Fockens,et al. Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients , 2008, Endoscopy.
[11] P. Fockens,et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.
[12] G. Triadafilopoulos,et al. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. , 2007, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[13] B. Overholt,et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.
[14] N. Soehendra,et al. Endoscopic mucosal resection of Barrett’s oesophagus containing dysplasia or intramucosal cancer , 2007, Postgraduate Medical Journal.
[15] R. Goeree,et al. Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[16] Kenneth K Wang,et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.
[17] M. Crowell,et al. Circumferential Ablation of Barrett Esophagus with Low Grade Dysplasia: One and Two Year Follow-Up of the AIM-LGD Trial , 2007 .
[18] C. D. Smith,et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system , 2007, Surgical Endoscopy.
[19] Patricia L. Blount,et al. Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus , 2007, The American Journal of Gastroenterology.
[20] V. Velanovich,et al. Endoscopic endoluminal radiofrequency ablation of Barrett’s esophagus in patients with fundoplications , 2007, Surgical Endoscopy.
[21] Bergein F Overholt,et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. , 2007, Gastrointestinal endoscopy.
[22] M. Scheurlen,et al. High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation , 2007, Scandinavian journal of gastroenterology.
[23] G. Falk,et al. Barrett's Esophagus at a Tertiary Care Center: Association of Age on Incidence and Prevalence of Dysplasia and Adenocarcinoma , 2006, The American Journal of Gastroenterology.
[24] D. Fleischer,et al. Successful Ablation of Barrett Esophagus (BE) with Dysplasia Using the Halo360 Ablation System: A Single-Center Experience , 2006 .
[25] R. Sampliner,et al. A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results , 2006, Gut.
[26] M. Stolte,et al. Ablation of Nonneoplastic Barrett's Mucosa Using Argon Plasma Coagulation with Concomitant Esomeprazole Therapy (APBANEX): A Prospective Multicenter Evaluation , 2006, The American Journal of Gastroenterology.
[27] R. Sampliner,et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] Bergein F Overholt,et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.
[29] L. Gossner,et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.
[30] J. Rubenstein,et al. The cost‐effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma , 2005, Alimentary pharmacology & therapeutics.
[31] Navtej S Buttar,et al. American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. , 2005, Gastroenterology.
[32] Kenneth K Wang,et al. American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma. , 2005, Gastroenterology.
[33] N. Shaheen. Advances in Barrett's esophagus and esophageal adenocarcinoma. , 2005, Gastroenterology.
[34] B. Edil,et al. Surgical treatment of esophageal high-grade dysplasia. , 2005, The Annals of thoracic surgery.
[35] S. Spechler,et al. Dysplasia in Barrett's Esophagus: Limitations of Current Management Strategies , 2005, The American Journal of Gastroenterology.
[36] A. Ruzzenente,et al. Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. , 2005, World journal of gastroenterology.
[37] T. Hastie,et al. Patient-Derived Health State Utilities for Gastroesophageal Reflux Disease , 2005, The American Journal of Gastroenterology.
[38] M. Vieth,et al. Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation. , 2005, World journal of gastroenterology.
[39] A. Ippoliti,et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. , 2005, Gastrointestinal endoscopy.
[40] K. Ragunath,et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: A randomized prospective trial assessing efficacy and cost-effectiveness , 2005, Scandinavian journal of gastroenterology.
[41] C J Stoddard,et al. Endoscopic ablation of Barrett's oesophagus: a randomized‐controlled trial of photodynamic therapy vs. argon plasma coagulation , 2004, Alimentary pharmacology & therapeutics.
[42] G. Sanders,et al. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. , 2004, Gastrointestinal endoscopy.
[43] M. Wallace,et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer , 2004, Alimentary pharmacology & therapeutics.
[44] J. Gama-Rodrigues,et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation: a prospective study after fundoplication. , 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[45] E. Steyerberg,et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial , 2004, Gut.
[46] E. Kuipers,et al. Oesophageal cancer incidence and mortality in patients with long-segment Barrett's Oesophagus after a mean follow-up of 12.7 years , 2004, Scandinavian journal of gastroenterology.
[47] L. Bonavina,et al. Barrett's esophagus: combined treatment using argon plasma coagulation and laparoscopic antireflux surgery. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[48] Masoud Panjehpour,et al. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.
[49] N. Nishioka,et al. Cost-Effectiveness of Photodynamic Therapy for Treatment of Barrett's Esophagus with High Grade Dysplasia , 2003, Digestive Diseases and Sciences.
[50] K. Hemming,et al. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[51] L. Bonavina,et al. Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[52] T. Stephenson,et al. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. , 2003, Endoscopy.
[53] S. Law,et al. Influence of the Route of Reconstruction on Morbidity, Mortality and Local Recurrence after Esophagectomy for Cancer , 2003, Digestive Surgery.
[54] L. Neumayer,et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. , 2003, The Journal of thoracic and cardiovascular surgery.
[55] John A. Cowan,et al. Complications and costs after high-risk surgery: where should we focus quality improvement initiatives? , 2003, Journal of the American College of Surgeons.
[56] B. Overholt,et al. What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis , 2003, Gut.
[57] J. Devière,et al. Long-term Follow-Up and Factors Predictive of Recurrence in Barrett's Esophagus Treated by Argon Plasma Coagulation and Acid Suppression , 2002, Endoscopy.
[58] J. de Caestecker,et al. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium , 2002, Gut.
[59] W H Henricks,et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma , 2002, Gut.
[60] M. Raimondo,et al. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. , 2002, Mayo Clinic proceedings.
[61] H. Bosworth,et al. Quality of life in patients with Barrett's esophagus undergoing surveillance , 2002, American Journal of Gastroenterology.
[62] M Dietel,et al. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. , 2002, Endoscopy.
[63] L. Gossner,et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. , 2002, Endoscopy.
[64] M. Sprangers,et al. Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences , 2002, British Journal of Cancer.
[65] Noel S Weiss,et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.
[66] J. Byrne,et al. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation , 2001, The British journal of surgery.
[67] J. Inadomi,et al. Unsedated Small-caliber Esophagogastroduodenoscopy (EGD): Less Expensive and Less Time-consuming Than Conventional EGD , 2001, Journal of clinical gastroenterology.
[68] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[69] R. Sampliner,et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. , 2001, JAMA.
[70] D. Faigel,et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. , 2001, Gastrointestinal endoscopy.
[71] K. Fuchs,et al. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of barrett’s esophagus , 2001, Journal of Gastrointestinal Surgery.
[72] S. Kavic,et al. Complications of endoscopy. , 2001, American journal of surgery.
[73] J K Greenson,et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.
[74] R. Sampliner,et al. Progression of Barretl's esophagus to high grade dysplasia and cancer: Preliminary results of the BEST (Barrett's esophagus study) trial , 2001 .
[75] E. Montgomery,et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. , 2001, Human pathology.
[76] J. Devière,et al. Argon Plasma Coagulation in the Treatment of Barrett’s High-Grade Dysplasia and In Situ Adenocarcinoma , 2001, Endoscopy.
[77] Prateek Sharma,et al. Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.
[78] R. Sandler,et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.
[79] A. Sonnenberg,et al. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? , 2000, American Journal of Gastroenterology.
[80] Gary Longton,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.
[81] C. Blaya,et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus , 2000, American Journal of Gastroenterology.
[82] L. Hernandez,et al. Comparison among the perforation rates of Maloney, balloon, and savary dilation of esophageal strictures. , 2000, Gastrointestinal endoscopy.
[83] P. Schauer,et al. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. , 2000, Surgery.
[84] A. Weston,et al. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus , 1999, American Journal of Gastroenterology.
[85] A. Weston,et al. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma , 1999, American Journal of Gastroenterology.
[86] G. Falk,et al. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999, American Journal of Gastroenterology.
[87] O. Cummings,et al. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. , 1999, Gastrointestinal endoscopy.
[88] J. Devière,et al. Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results , 1998, Gut.
[89] G. Tytgat,et al. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.
[90] Kenneth K Wang,et al. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.
[91] P. Schoenfeld,et al. Effectiveness and patient satisfaction with nurse-directed treatment of barrett's esophagus , 1998, American Journal of Gastroenterology.
[92] A. Schned,et al. The Development of Dysplasia and Adenocarcinoma During Endoscopic Surveillance of Barrett’s Esophagus , 1998 .
[93] R. Whyte,et al. Functional outcome after surgical treatment of esophageal perforation. , 1997, The Annals of thoracic surgery.
[94] A. Bhattacharyya,et al. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. , 1997, The American journal of gastroenterology.
[95] M. Helfand,et al. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.
[96] F. Ellis,et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. , 1997, The Journal of thoracic and cardiovascular surgery.
[97] S. Re,et al. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997 .
[98] M C Weinstein,et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.
[99] Milton C. Weinstein,et al. Recommendations for Reporting Cost-effectiveness Analyses , 1996 .
[100] M F Chan,et al. Complications of upper gastrointestinal endoscopy. , 1996, Gastrointestinal endoscopy clinics of North America.
[101] J. Peters,et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.
[102] J B Wong,et al. A guide for surveillance of patients with Barrett's esophagus. , 1994, The American journal of gastroenterology.
[103] F. Duhaylongsod,et al. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. , 1993, The Journal of thoracic and cardiovascular surgery.
[104] F. Ellis,et al. Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.
[105] W. Hop,et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. , 1992, Gut.
[106] P. Pairolero,et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? , 1992, The Annals of thoracic surgery.
[107] D. Fleischer,et al. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. , 1991, Gastrointestinal endoscopy.
[108] M. Classen,et al. Complications of Diagnostic Gastrointestinal Endoscopy , 1990, Endoscopy.
[109] J. G. van den Tweel,et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.
[110] Angelita Habr-Gama,et al. Complications and hazards of gastrointestinal endoscopy , 1989, World Journal of Surgery.
[111] K. Moghissi,et al. Instrumental perforations of the oesophagus and their management. , 1988, Thorax.
[112] J. Mayberry,et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.
[113] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.
[114] W G Doos,et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? , 1984, Gastroenterology.
[115] S. Pauker,et al. The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.
[116] F. Ellis,et al. Esophagogastrectomy: A Safe, Widely Applicable, and Expeditious Form of Palliation for Patients with Carcinoma of the Esophagus and Cardia , 1983, Annals of surgery.
[117] Y. Wu,et al. Chinese experience in the surgical treatment of carcinoma of the esophagus. , 1979, Annals of surgery.
[118] C. Sugawa,et al. Endoscopic Complications: Results of the 1974 American Society for Gastrointestinal Endoscopy Survey , 1976 .
[119] R. BarreraCacicedo,et al. [Cancer of the esophagus]. , 1960, Revista medica cubana.
[120] NASOPHARYNGEAL CARCINOMA,et al. The British Journal of Surgery , 1915, The Indian Medical Gazette.
[121] E. Kuipers,et al. Genomic analysis of Barrett's esophagus after ablative therapy: Persistence of genetic alterations at tumor suppressor loci , 2006, International journal of cancer.
[122] P. Devitt,et al. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. , 2004, Gastrointestinal endoscopy.
[123] D. Faigel,et al. Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus. , 2002, Gastrointestinal Endoscopy.
[124] Dawn Provenzale,et al. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.
[125] R. Jakobs,et al. Management of esophageal perforations after therapeutic upper gastrointestinal endoscopy. , 1997, Scandinavian journal of gastroenterology.
[126] M. Diebold,et al. [Reproducibility of histological criteria of dysplasia in Barrett mucosa]. , 1994, Gastroenterologie clinique et biologique.
[127] M. Catarci,et al. Iatrogenic perforations of the esophagus. , 1993, International surgery.
[128] T. Demeester,et al. Selective therapeutic approach to cancer of the lower esophagus and cardia. , 1988, The Journal of thoracic and cardiovascular surgery.
[129] D. Cosgrove,et al. Cancer of the esophagus. The Cleveland Clinic experience. , 1986, Annals of surgery.
[130] D. Skinner. En bloc resection for neoplasms of the esophagus and cardia. , 1983, The Journal of thoracic and cardiovascular surgery.